|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.205 USD | -12.23% |
|
+0.89% | +182.05% |
| Dec. 09 | Immix Biopharma announces closing of upsized $100 million underwritten offering of common stock and pre-funded warrants | RE |
| Dec. 08 | Immix Biopharma Prices $100 Million Offering | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | $7.95 | +12.45% | 2 | |||||
| €797.32 | +5.86% | 13 | ||||||
| $224.89 | +14.15% | 18 | ||||||
| CN¥126.08 | +34.06% | 19 | ||||||
| $118.09 | +46.4% | 19 | ||||||
| DKK 2,083.23 | +3.39% | 14 | ||||||
| HK$35.84 | +18.09% | 25 | ||||||
| HK$155.28 | +37.31% | 21 | ||||||
| $24.26 | +82.58% | 13 | ||||||
| HK$532.56 | +21.42% | 17 | ||||||
| $571.13 | -0.05% | 15 | ||||||
| $44.94 | +9.94% | 18 | ||||||
| $61.58 | -12.14% | 12 | ||||||
| $141.82 | +35.33% | 17 | ||||||
| $79.56 | +25.58% | 18 | ||||||
| - | - | - | - | - | ||||
| - | $97 | +0.07% | 12 | |||||
| Average | 318.85 | +20.90% | 16 | ||||||
| Weighted average by Cap. | 415.17 | +20.86% | 17 |
- Stock Market
- Equities
- IMMX Stock
- Sector Immix Biopharma, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
